Cocrystal Pharma, Inc. (COCP): Operating Income
-$9.02M
Year ended 2025-12-31
-$10.11M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$9.02M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$17.88M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$18.56M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$38.83M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$14.22M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$9.59M | n/m | 2022-03-23, From 2020-01-01 |
| 2019-12-31 | -$48.41M | n/m | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | -$62.92M | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$8.26M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$105.82M | n/m | 2018-03-21, From 2016-01-01 |
| 2015-12-31 | -$53.95M | n/m | 2018-03-21, From 2015-01-01 |
| 2014-12-31 | -$5.80M | n/m | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | -$4.08M | n/c | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | -$2.55M | n/c | 2014-03-31, From 2012-01-01 |
| 2011-12-31 | -$3.89M | n/m | 2013-04-01, From 2011-01-01 |
| 2010-12-31 | -$32.0K | n/a | 2012-04-16, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | -$9.02M | n/m |
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | -$24.27M | n/m |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | -$16.65M | n/m |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | -$9.95M | n/m |
| Kala Bio, Inc. (KALA) | 2025-12-31 | -$39.16M | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | -$4.97M | n/m |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | -$34.36M | n/m |
| Oragenics Inc (OGEN) | 2025-12-31 | -$9.36M | n/m |
| Indaptus Therapeutics, Inc. (INDP) | 2025-12-31 | -$19.83M | n/m |
Compare COCP, MAIA, FBLG, CANF side by side · Screen every company in Pharmaceutical Preparations ↗